Entity family

Browse diseases

Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.

26articles mentioning diseases

28disease mentions

1distinct diseases extracted

0%of mentions human-reviewed

Active filtersEntity: Metabolic dysfunction-associated steatohepatitis ×

Metabolic dysfunction-associated steatohepatitis

This disease is selected. Its supporting articles are shown below.

Metabolic Dysfunction-Associated Steatohepatitis26

Articles mentioning Metabolic dysfunction-associated steatohepatitis

26 articles · page 3 of 3

P4 Treatment with resmetirom for up to two years led to improvement in liver stiffness, fibrosis biomarkers, fibrosis scores and portal hypertension risk in 122 patients with compensated MASH cirrhosis

gutjnl · abstract · 2025-10-06 · 1 matching annotations

86.5%

MASH metabolic dysfunction-associated steatohepatitis NASH CSPH MASH cirrhosis portal hypertension Resmetirom

…trate clinical benefit in MAESTRO-NASH OUTCOMES, an ongoing 845 MASH cirrhosis patient clinical outcome study.…

P5 Pegozafermin treatment demonstrates long-term benefit in subjects with metabolic dysfunction-associated steatohepatitis and fibrosis: results from the Phase 2b ENLIVEN clinical trial

gutjnl · abstract · 2025-10-06 · 1 matching annotations

76.1%

T2DM MASH F2/F3 fibrosis obesity metabolic dysfunction-associated steatohepatitis PGZ Pegozafermin

…iopsy-proven F2/F3 fibrosis. Co-morbidities such as obesity and T2DM are common in patients with MASH and may be treated with glucag…